Patients with type 2 diabetes who received sodium-glucose cotransporter-2 inhibitors demonstrated a nearly 50% lower risk for systemic autoimmune rheumatic disease vs. those who received dipeptidyl ...

Dry eye has emerged as an early warning sign of autoimmune disease, appearing roughly three years before many patients receive a formal diagnosis. That gap reframes a common irritation as a potential ...